IMAC (NASDAQ:IMAC) and Hanger (OTCMKTS:HNGR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, analyst recommendations and institutional ownership.

Profitability

This table compares IMAC and Hanger’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
IMAC -41.81% -78.89% -30.92%
Hanger N/A N/A N/A

Institutional and Insider Ownership

0.7% of IMAC shares are owned by institutional investors. Comparatively, 3.6% of Hanger shares are owned by institutional investors. 2.4% of Hanger shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares IMAC and Hanger’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
IMAC $15.13 million 1.10 -$6.50 million ($0.84) -1.98
Hanger N/A N/A N/A N/A N/A

Hanger has lower revenue, but higher earnings than IMAC.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for IMAC and Hanger, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IMAC 0 1 1 0 2.50
Hanger 0 0 0 0 N/A

IMAC presently has a consensus target price of $4.50, indicating a potential upside of 171.08%. Given IMAC’s higher possible upside, equities research analysts clearly believe IMAC is more favorable than Hanger.

Summary

Hanger beats IMAC on 5 of the 8 factors compared between the two stocks.

About IMAC

IMAC Holdings, Inc. operates a chain of integrated medicine and chiropractic regeneration centers. The company's outpatient clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. As of September 17, 2018, it had 11 clinics, including 6 owned and 5 managed clinics in Kentucky, Missouri, and Tennessee, the United States. The company was founded in 2000 and is based in Brentwood, Tennessee.

About Hanger

Hanger, Inc. provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. It operates through two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and provides payor network contracting services to other O&P providers. The Products & Services segment procures and distributes O&P parts, componentry, and devices to independent O&P providers; and develops specialized rehabilitation technologies and provides evidence-based clinical programs for post-acute rehabilitation to patients at approximately 4,000 skilled nursing and post-acute providers. This segment also manufactures and sells therapeutic footwear for diabetic patients in the podiatric market. As of May 14, 2018, the company owned and operated approximately 800 patient care clinics in the United States. The company was formerly known as Hanger Orthopedic Group, Inc. and changed its name to Hanger, Inc. in June 2012. Hanger, Inc. was founded in 1861 and is headquartered in Austin, Texas.

Receive News & Ratings for IMAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAC and related companies with MarketBeat.com's FREE daily email newsletter.